Literature DB >> 2453124

Hepatocellular carcinoma. A comparison of Oriental and Caucasian patients.

C H Scudamore1, J Ragaz, A M Kluftinger, D A Owen.   

Abstract

Hepatocellular carcinoma is a very malignant tumor that affects both Caucasian and Oriental populations. In the Caucasian patient, it frequently arises in a background of cirrhosis, most commonly the alcoholic type. In the present study, the alpha-feto-protein level was increased in less than half of the Caucasian patients. In comparison, hepatocellular carcinoma in Oriental patients most often occurs in livers with postinfectious cirrhosis. In the present study, both hepatitis B surface antigen and an increased alpha-fetoprotein level were present in three of four patients. If the tumor is present, however, it appears to behave similarly in both ethnic groups. Without resection, the prognosis is poor, regardless of the presence or absence of underlying cirrhosis or hepatitis B surface antigen status. A tissue diagnosis of hepatocellular carcinoma is most readily made by ultrasonographically guided fine-needle aspiration, which has an 81 percent sensitivity. The most important factor affecting survival is surgical resection. Clearly, the stage at diagnosis is also crucial, but even in more advanced disease, operation can improve survival. It also appears that an increased carcinoembryonic antigen level above normal or a markedly increased alpha-fetoprotein level or both are associated with poor survival. However, whether this is a reflection of tumor size alone, or in fact represents a more aggressive tumor is uncertain and will require further study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453124     DOI: 10.1016/s0002-9610(88)80138-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.

Authors:  E Kouroumalis; P Skordilis; K Thermos; A Vasilaki; J Moschandrea; O N Manousos
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

2.  JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis.

Authors:  You Wang; Ya-Nan Yu; Shu Song; Tie-Jun Li; Jing-Ying Xiang; Hong Zhang; Mu-Dan Lu; Fang Ji; Ling-Qing Hu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

3.  Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.

Authors:  G Otto; U Heuschen; W J Hofmann; G Krumm; U Hinz; C Herfarth
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

4.  Hepatocellular carcinoma with or without cirrhosis: a comparison of CT and angiographic presentations in the United States and Japan.

Authors:  Y Yamashita; M Takahashi; Y Baba; S Kanazawa; C Charnsangavej; D Yang; S Wallace
Journal:  Abdom Imaging       Date:  1993

5.  Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients.

Authors:  B Ringe; R Pichlmayr; C Wittekind; G Tusch
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

6.  Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections.

Authors:  H Bismuth; L Chiche; D Castaing
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.